Of note, the m6A reader YTHDF2 is reportedly highly expressed and maintains the oncogene characteristics of glioma stem cells (GSCs)18, highlighting the potential of therapeutic targets generated from m6A-modified circRNAs. The gene discussed is YTHDF2; the disease is central nervous system cancer.